Contributors

Andrea Amalfitano, do, phd • Departments of Pediatrics, Molecular Genetics and Microbiology, and Pathology, Duke University Medical Center, Durham, NC Fabrice Andre, md • Department of Clinical Biology, Institut Gustave Roussy (IGR), Villejuif, France

Philip M. Arlen, md • Laboratory of Tumor Immunology and Biology, Center for

Cancer Research, National Cancer Institute, Bethesda, MD Jory R. Baldridge, phd • Corixa Corporation, Hamilton, MT

David Berd, md • Division of Medical Oncology, Department of Medicine, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

Michael Bereta, phd • Department of Surgery and Pathology, Columbia University, New York, NY

Carmen M. Berger, md • Division of Dermatology, University of Washington, Seattle, WA Malaya Bhattacharya-Chatterjee, phd • Department of Internal Medicine and the Barrett Cancer Center, University of Cincinnati, Cincinnati, OH

Gerard C. Blobe, md, phd • Departments of Medicine and Pharmacology and Cancer

Biology, Duke University Medical Center, Durham, NC Sunil K. Chatterjee, phd • Department of Internal Medicine and the Barrett Cancer

Center, University of Cincinnati, Cincinnati, OH Nathalie Chaput, pharmd • Department of Clinical Biology, Institut Gustave Roussy (IGR), Villejuif, France

Timothy M. Clay, phd • Department of Surgery, Duke University Medical Center, Durham, NC

Peter A. Cohen, md • Center for Surgery Research, The Cleveland Clinic Foundation, Cleveland, OH

Diane M. Da Silva, phd • Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL

Mary L. Disis, md • Division of Oncology, University of Washington, Seattle, WA Madhav V. Dhodapkar, md • Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, and Hematology Service, Memorial Sloan Kettering Cancer Center, New York, NY Gretchen L. Eiben, bs • Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL

Leisha A. Emens, md, phd • Department of Oncology, The Sidney Kimmel

Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD

Steven C. Fausch, bs • Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL

Robert A. Figlin, md • Departments of Medicine and Urology, University of California,

Los Angeles, CA John Fikes, phd • Epimmune Inc., San Diego, CA Kenneth A. Foon, md • Abgenix Inc., Fremont, CA

Dmitry Gabrilovich, md, phd • H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL

Jennifer Garst, md • Department of Medicine, Duke University Medical Center, Durham, NC

John Gathuru, phd • Laboratory of Tumor Vaccinology, Department of Medicine,

Memorial Sloan-Kettering Cancer Center, New York, NY Steven D. Gillies, phd • EMD Lexigen Research Center Corporation, Bedford, MA Barbara J. Gitlitz, md • Department of Medicine, University of California, Los Angeles, CA Michael W. Graner, phd • Department of Pediatrics and Steele Memorial Children's

Research Center, University of Arizona, Tucson, AZ James L. Gulley, md, phd • Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD Zachary Hartman, ba • Departments of Pediatrics and Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC Dorothee Herlyn, dvm • The Wistar Institute, University of Pennsylvania, Philadelphia, PA

Amy Hobeika, phd • Department of Surgery, Duke University Medical Center, Durham, NC

Elizabeth M. Jaffee, md • Departments of Oncology, Pathology and Immunology,

The Johns Hopkins University School of Medicine, Baltimore, MD Emmanuel Katsanis, md • Department of Pediatrics and Steele Memorial Children's

Research Center, University of Arizona, Tucson, AZ W. Martin Kast, phd • Cancer Immunology Program, Cardinal Bernardin Cancer

Center, Loyola University Chicago, Maywood, IL Howard L. Kaufman, md • Department of Surgery and Pathology, Columbia University, New York, NY

Hyung L. Kim, md • Department of Urology, University of California, Los Angeles, CA Keith L. Knutson, phd • Division of Oncology, University of Washington, Seattle, WA

Amanda M. Krier, bs • Cancer Immunology Program, Cardinal Bernardin Cancer

Center, Loyola University Chicago, Maywood, IL Caroline Le Poole, phd • Cancer Immunology Program, Cardinal Bernardin Cancer

Center, Loyola University Chicago, Maywood, IL Philip O. Livingston, md • Laboratory of Tumor Vaccinology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

H. Kim Lyerly, md • Departments of Surgery, Immunology, Pathology,

Duke University Medical Center, Durham, NC John L. Marshall, md • Developmental Therapeutics and GI Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC

Boris Minev, md • UCSD Comprehensive Cancer Center, University of California, San Diego, CA

Malcolm S. Mitchell, md • Barbara Ann Karmanos Cancer Institute, The Detroit

Medical Center, Wayne State University, Detroit, MI Michael A. Morse, md • Department of Medicine, Duke University Medical Center, Durham, NC

Paul J. Mosca, md, phd • Department of Surgery, Duke University Medical Center, Durham, NC

Sally P. Mossman, phd • Corixa Corporation, Seattle, WA

Edward L. Nelson, md • Division of Hematology/Oncology and Department of Molecular Biology and Biochemistry, University of California, Irvine, CA Donna Niedzwiecki, phd • Department of Bioinformatics and Bioinformatics,

Duke University Medical Center, Durham, NC Michael I. Nishimura, phd • Department of Surgical Oncology, The University of Chicago Medical Center, Chicago, Maywood, IL Michael J. Palmowski, dphil • Weatherall Institute of Molecular Medicine,

University of Oxford, Oxford, UK Megan E. Papineau, bs • Cancer Immunology Program, Cardinal Bernardin Cancer

Center, Loyola University Chicago, Maywood, IL Vladimir Pisarev, md, phd • Eppley Institute for Research in Cancer and Allied

Diseases, University of Nebraska Medical Center, Omaha, NE Gregory E. Plautz, md • Center for Surgery Research, The Cleveland Clinic

Foundation, Cleveland, OH Raj K. Puri, md, phd • Office of Cellular, Tissue and Gene Therapies, Center for

Biologics Evaluation & Research, Food and Drug Administration, Rockville, MD Govind Ragupathi, phd • Laboratory of Tumor Vaccinology, Department of Medicine,

Memorial Sloan-Kettering Cancer Center, New York, NY Paul F. Robbins, phd • Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD Michael L. Salgaller, phd • Toucan Capital Corp., Bethesda, MD Lupe G. Salazar, md • Division of Oncology, University of Washington, Seattle, WA

N. E. C. Schartz, md • Department of Clinical Biology, Institut Gustave Roussy (IGR), Villejuif, France; Department of Dermatology 2, AP-HP Hôpital Saint-Louis, Paris, France

Kathy Schiffman, pa-c • Division of Oncology, University of Washington, Seattle, WA

Jeffrey Schlom, phd • Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Suyu Shu, phd • Center for Surgery Research, The Cleveland Clinic Foundation, Cleveland, OH

Richard Simon, dsc • Biometric Research Branch, National Cancer Institute, Rockville, MD

Caroline Smith, md • Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK

Jonathan Smith, PhD • AlphaVax, Research Triangle Park, NC

Susan E. Smith, md • Arizona Cancer Center, University of Arizona, Tucson, AZ

Rajasekharan Somasundaram, PhD • The Wistar Institute, University of Pennsylvania, Philadelphia, PA

Paul M. Sondel, md, PhD • Comprehensive Cancer Center, University of Wisconsin, Madison, WI

Alison T. Stopeck, md • Arizona Cancer Center, University of Arizona, Tucson, AZ

Mark O. Thornton, md, mph, PhD • Division of Therapeutic Biologic Oncology Products, Center for Drug Evaluation and Review, Food and Drug Administration, Rockville, MD

Eric Toloza, md, PhD • Department of Surgery, Duke University Medical Center, Durham, NC

Jeffrey Weber, md, PhD • USC/Norris Cancer Center, University of Southern

California, Los Angeles, CA David E. Weng, md, PhD • Center for Surgery Research, The Cleveland Clinic

Foundation, Cleveland, OH Keith Wonnacott, PhD • Office of Cellular, Tissue and Gene Therapies, Center for

Biologics Evaluation & Research, Food and Drug Administration, Rockville, MD Alexandra S. Worobec, md • Division of Clinical Trial Design and Analysis, Center for Biologics Evaluation & Research, Food and Drug Administration, Rockville, MD Jiangchun Xu, md, PhD • Corixa Corporation, Seattle, WA

Qing Yi, md, PhD • Myeloma Institute for Research and Therapy and Arkansas Cancer

Research Center, University of Arkansas for Medical Sciences, Little Rock, AR Tianqian Zhang, PhD • The Wistar Institute, University of Pennsylvania, Philadelphia, PA Susan Hand Zimmermann, PhD • Corixa Corporation, Seattle, WA Laurence Zitvogel, md, PhD • Department of Clinical Biology, Institut Gustave Roussy (IGR), Villejuif, France

Includes eBook/PDA

Was this article helpful?

0 0

Post a comment